Beam Suntory Inc. (BEAM) [Rocket]

Overview

Beam Suntory Inc. (BEAM)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
05/26/2020	GN	Beam Therapeutics to Present at Jefferies 2020 Virtual Healthcare Conference
05/12/2020	GN	Beam Therapeutics Reports Additional Data at ASGCT Annual Meeting and First Quarter 2020 Financial Results
04/28/2020	GN	Beam Therapeutics to Present First Data Highlighting Base Editing Program for Alpha-1 Antitrypsin Deficiency at 23rd ASGCT Annual Meeting
04/28/2020	GN	Beam Therapeutics to Present Updated Data Highlighting Base Editing Programs for Sickle Cell Disease at 23rd ASGCT Annual Meeting
03/30/2020	GN	Beam Therapeutics Reports Business Updates and Full Year 2019 Financial Results
05/02/2014	4	Form 4 - Statement of changes in beneficial ownership of securities
05/02/2014	4	Hine C Clarkson (SVP Corp Comm & Public Affairs) has filed a Form 4 on Beam Suntory Inc.

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-13	Dec-31-12	Dec-31-11	Dec-31-10	Dec-31-09	Dec-31-08	Dec-31-07	Dec-31-06
Revenues	2,547.3	2,459.7	2,299.0	2,094.9	1,980.3	7,608.9	8,563.1	8,521.0
Revenue growth	3.6%	7.0%	9.7%	5.8%	-74.0%	-11.1%	0.5%	23.7%
Cost of goods sold	1,065.9	1,022.9	985.6	865.0	782.7	4,044.8	4,564.6	4,476.8
Gross profit	1,481.4	1,436.8	1,313.4	1,229.9	1,197.6	3,564.1	3,998.5	4,044.2
Gross margin	58.2%	58.4%	57.1%	58.7%	60.5%	46.8%	46.7%	47.5%
Selling, general and administrative	813.8	807.3				1,997.8	2,035.8	2,026.6
Sales and marketing			358.7	307.6	275.7
General and administrative			430.0	416.1	384.2
EBITA	667.6	629.5	452.2	508.8	556.8	1,065.2	1,497.9	1,512.6
EBITA margin	26.2%	25.6%	19.7%	24.3%	28.1%	14.0%	17.5%	17.8%
Amortization of intangibles			27.6	34.9	36.4	52.3	48.1	43.5
EBIT	667.6	629.5	424.6	473.9	520.4	1,012.9	1,449.8	1,469.1
EBIT margin	26.2%	25.6%	18.5%	22.6%	26.3%	13.3%	16.9%	17.2%
Pre-tax income	430.2	385.7	159.4	345.7	248.0	188.4	1,120.2	1,179.3
Income taxes	0.0	0.0	39.8	36.2	13.3	95.6	346.3	299.3
Tax rate	0.0%	0.0%	25.0%	10.5%	5.4%	50.7%	30.9%	25.4%
Earnings from continuing ops	430.2	385.7	115.1	300.7	229.9	158.1	749.5	812.1
Earnings from discontinued ops			787.2	186.5	12.4	152.5	13.1	18.0
Net income	430.2	385.7	902.3	487.2	242.3	310.6	762.6	830.1
Net margin	16.9%	15.7%	39.2%	23.3%	12.2%	4.1%	8.9%	9.7%

Diluted EPS			$0.73	$1.95	$1.51	$1.03	$4.79	$5.31
Shares outstanding (diluted)			157.8	154.3	151.8	153.7	156.5	153.0

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.